{"id":2251,"date":"2014-09-19T15:21:15","date_gmt":"2014-09-19T15:21:15","guid":{"rendered":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?p=2251"},"modified":"2014-09-19T15:53:39","modified_gmt":"2014-09-19T15:53:39","slug":"myokardinfarkt","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/","title":{"rendered":"Myokardinfarkt"},"content":{"rendered":"<p>Myokardinfarkt Der Myokardinfarkt, auch Herzinfarkt, umgangssprachlich Herzschlag, Herzanfall oder Herzattacke, ist ein akutes und lebensbedrohliches Ereignis infolge einer Erkrankung des Herzens. Eine in der Humanmedizin gebr\u00e4uchliche Abk\u00fcrzung ist AMI (acute myocardial infarction). Es handelt sich um ein Absterben (Infarkt) von Teilen des Herzmuskels (Myokard) auf Grund einer Durchblutungsst\u00f6rung (Isch\u00e4mie), die in der Regel l\u00e4nger als [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Myokardinfarkt Der Myokardinfarkt, auch Herzinfarkt, umgangssprachlich Herzschlag, Herzanfall oder Herzattacke, ist ein akutes und lebensbedrohliches Ereignis infolge einer Erkrankung des Herzens. Eine in der Humanmedizin gebr\u00e4uchliche Abk\u00fcrzung ist AMI (acute myocardial infarction). Es handelt sich um ein Absterben (Infarkt) von Teilen des Herzmuskels (Myokard) auf Grund einer Durchblutungsst\u00f6rung (Isch\u00e4mie), die in der Regel l\u00e4nger als [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[1],"tags":[1315,128,1344,75,1343,76,1314,77,643,1345,129,136,1316,139,1346,1317,1318,1319,1320,1321,1347,1322,1323,1324,1348,1349,78,1350,1325,1326,1351,79,1327,1352,1328,1353,1354,74,1329,1355,1356,1330,527,528,87,85,1331,1332,88,1333,1334,1335,1357,1358,1359,1360,1336,1361,324,1362,948,1363,1337,1364,106,644,1338,1339,1365,1366,1340,1341,1342],"class_list":["post-2251","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-abciximab","tag-acetylsalicylsaeure","tag-admiral-studie","tag-akutes-koronarsyndrom","tag-alteplase","tag-angina-pectoris","tag-arctic-studie","tag-arteriosklerose","tag-aspirin-resistenz","tag-assent-i-studie","tag-azetylsalizylsaeure","tag-caprie-studie","tag-capture-studie","tag-clopidogrel","tag-compass-studie","tag-dipyridamol","tag-epic-studie","tag-epilog-studie","tag-epistent-studie","tag-eptifibatid","tag-escobar-studie","tag-fradafiban","tag-gp-iibiiia-rezeptor-antagonisten","tag-gp-iibiiia-rezeptor-blocker","tag-gusto-iib-studie","tag-gusto-iii-studie","tag-herzinfarkt","tag-hirudin","tag-impact-ii-studie","tag-instabile-angina-pectoris","tag-intime-studie","tag-koronare-herzkrankheit","tag-lamifiban","tag-lanoteplase","tag-lefradafiban","tag-lysetherapie","tag-miti-studie","tag-myokardinfarkt","tag-non-q-wave-myokardinfarkt","tag-npa","tag-nrmi-2-register","tag-paragon-studie","tag-pci","tag-perkutane-koronarintervention","tag-perkutane-transluminale-koronare-angioplastie","tag-prasugrel","tag-prism-plus-studie","tag-prism-studie","tag-ptca","tag-pursuit-studie","tag-rapport-studie","tag-restore-studie","tag-reteplase","tag-rpa","tag-saruplase","tag-shock-studie","tag-sibrafiban","tag-speed-studie","tag-stent","tag-stent-pami-studie","tag-stents","tag-streptokinase","tag-superaspirine","tag-thrombolysetherapie","tag-thrombozytenaggregationshemmer","tag-ticlopidin","tag-timi-14-studie","tag-tirofiban","tag-tnk-tpa","tag-tpa","tag-trapidil","tag-vanquish-studie","tag-xemilofiban"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myokardinfarkt - Der Arzneimittelbrief<\/title>\n<meta name=\"description\" content=\"Myokardinfarkt - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken --&gt;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myokardinfarkt - Der Arzneimittelbrief\" \/>\n<meta property=\"og:description\" content=\"Myokardinfarkt - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken --&gt;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-19T15:21:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-09-19T15:53:39+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg\" \/>\n<meta name=\"author\" content=\"NBF\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NBF\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"11\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/\"},\"author\":{\"name\":\"NBF\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/0be2a0edbca5eeb8b297cd04e33dd361\"},\"headline\":\"Myokardinfarkt\",\"datePublished\":\"2014-09-19T15:21:15+00:00\",\"dateModified\":\"2014-09-19T15:53:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/\"},\"wordCount\":2166,\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"keywords\":[\"Abciximab\",\"Acetylsalicyls\u00e4ure\",\"ADMIRAL-Studie\",\"Akutes Koronarsyndrom\",\"Alteplase\",\"Angina pectoris\",\"ARCTIC-Studie\",\"Arteriosklerose\",\"Aspirin-Resistenz\",\"ASSENT-I-Studie\",\"Azetylsalizyls\u00e4ure\",\"CAPRIE-Studie\",\"CAPTURE-Studie\",\"Clopidogrel\",\"COMPASS-Studie\",\"Dipyridamol\",\"EPIC-Studie\",\"EPILOG-Studie\",\"EPISTENT-Studie\",\"Eptifibatid\",\"ESCOBAR-Studie\",\"Fradafiban\",\"GP-IIb\\\/IIIa-Rezeptor-Antagonisten\",\"GP-IIb\\\/IIIa-Rezeptor-Blocker\",\"GUSTO IIb-Studie\",\"GUSTO III-Studie\",\"Herzinfarkt\",\"Hirudin\",\"IMPACT-II-Studie\",\"Instabile Angina pectoris\",\"InTIME-Studie\",\"Koronare Herzkrankheit\",\"Lamifiban\",\"Lanoteplase\",\"Lefradafiban\",\"Lysetherapie\",\"MITI-Studie\",\"Myokardinfarkt\",\"Non-Q-Wave-Myokardinfarkt\",\"NPA\",\"NRMI-2-Register\",\"PARAGON-Studie\",\"PCI\",\"Perkutane Koronarintervention\",\"Perkutane transluminale koronare Angioplastie\",\"Prasugrel\",\"PRISM-PLUS-Studie\",\"PRISM-Studie\",\"PTCA\",\"PURSUIT-Studie\",\"RAPPORT-Studie\",\"RESTORE-Studie\",\"Reteplase\",\"RPA\",\"Saruplase\",\"SHOCK-Studie\",\"Sibrafiban\",\"SPEED-Studie\",\"Stent\",\"Stent-PAMI-Studie\",\"Stents\",\"Streptokinase\",\"Superaspirine\",\"Thrombolysetherapie\",\"Thrombozytenaggregationshemmer\",\"Ticlopidin\",\"TIMI 14-Studie\",\"Tirofiban\",\"TNK-tPA\",\"TPA\",\"Trapidil\",\"VANQUISH-Studie\",\"Xemilofiban\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/\",\"name\":\"Myokardinfarkt - Der Arzneimittelbrief\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"datePublished\":\"2014-09-19T15:21:15+00:00\",\"dateModified\":\"2014-09-19T15:53:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/0be2a0edbca5eeb8b297cd04e33dd361\"},\"description\":\"Myokardinfarkt - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"contentUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/myokardinfarkt\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myokardinfarkt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/0be2a0edbca5eeb8b297cd04e33dd361\",\"name\":\"NBF\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g\",\"caption\":\"NBF\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myokardinfarkt - Der Arzneimittelbrief","description":"Myokardinfarkt - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/","og_locale":"de_DE","og_type":"article","og_title":"Myokardinfarkt - Der Arzneimittelbrief","og_description":"Myokardinfarkt - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2014-09-19T15:21:15+00:00","article_modified_time":"2014-09-19T15:53:39+00:00","og_image":[{"url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","type":"","width":"","height":""}],"author":"NBF","twitter_misc":{"Verfasst von":"NBF","Gesch\u00e4tzte Lesezeit":"11\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/"},"author":{"name":"NBF","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/0be2a0edbca5eeb8b297cd04e33dd361"},"headline":"Myokardinfarkt","datePublished":"2014-09-19T15:21:15+00:00","dateModified":"2014-09-19T15:53:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/"},"wordCount":2166,"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","keywords":["Abciximab","Acetylsalicyls\u00e4ure","ADMIRAL-Studie","Akutes Koronarsyndrom","Alteplase","Angina pectoris","ARCTIC-Studie","Arteriosklerose","Aspirin-Resistenz","ASSENT-I-Studie","Azetylsalizyls\u00e4ure","CAPRIE-Studie","CAPTURE-Studie","Clopidogrel","COMPASS-Studie","Dipyridamol","EPIC-Studie","EPILOG-Studie","EPISTENT-Studie","Eptifibatid","ESCOBAR-Studie","Fradafiban","GP-IIb\/IIIa-Rezeptor-Antagonisten","GP-IIb\/IIIa-Rezeptor-Blocker","GUSTO IIb-Studie","GUSTO III-Studie","Herzinfarkt","Hirudin","IMPACT-II-Studie","Instabile Angina pectoris","InTIME-Studie","Koronare Herzkrankheit","Lamifiban","Lanoteplase","Lefradafiban","Lysetherapie","MITI-Studie","Myokardinfarkt","Non-Q-Wave-Myokardinfarkt","NPA","NRMI-2-Register","PARAGON-Studie","PCI","Perkutane Koronarintervention","Perkutane transluminale koronare Angioplastie","Prasugrel","PRISM-PLUS-Studie","PRISM-Studie","PTCA","PURSUIT-Studie","RAPPORT-Studie","RESTORE-Studie","Reteplase","RPA","Saruplase","SHOCK-Studie","Sibrafiban","SPEED-Studie","Stent","Stent-PAMI-Studie","Stents","Streptokinase","Superaspirine","Thrombolysetherapie","Thrombozytenaggregationshemmer","Ticlopidin","TIMI 14-Studie","Tirofiban","TNK-tPA","TPA","Trapidil","VANQUISH-Studie","Xemilofiban"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/","name":"Myokardinfarkt - Der Arzneimittelbrief","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/#primaryimage"},"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","datePublished":"2014-09-19T15:21:15+00:00","dateModified":"2014-09-19T15:53:39+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/0be2a0edbca5eeb8b297cd04e33dd361"},"description":"Myokardinfarkt - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/#primaryimage","url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","contentUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/myokardinfarkt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Myokardinfarkt"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/0be2a0edbca5eeb8b297cd04e33dd361","name":"NBF","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g","caption":"NBF"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/2251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=2251"}],"version-history":[{"count":13,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/2251\/revisions"}],"predecessor-version":[{"id":2264,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/2251\/revisions\/2264"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=2251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=2251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=2251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}